Atlas Trials

GeoVax, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GeoVax, Inc.

RecordFirmDate
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer (NCT04977024)GeoVax, Inc.2021-09-27
A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection (NCT04639466)GeoVax, Inc.2020-11-19
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer (NCT03754933)GeoVax, Inc.2019-02-11

Track GeoVax, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.